"The biggest reform to China's health system": did the zero-markup drug policy achieve its goal at traditional Chinese medicines county hospitals?
- PMID: 31363744
- DOI: 10.1093/heapol/czz053
"The biggest reform to China's health system": did the zero-markup drug policy achieve its goal at traditional Chinese medicines county hospitals?
Abstract
The zero-markup drug policy (ZMDP) was heralded as the biggest reform to China's modern health system. However, there have been a very limited number of investigations of the ZMDP at county hospital level, and those limited county hospital studies have several limitations in terms of sample representativeness and study design. We investigated the overall and dynamic effects of ZMDP at traditional Chinese medicine (TCM) county hospitals. We obtained longitudinal data from all TCM county hospitals in 2004-16 and the implementation year of ZMDP for each hospital. We used differences-in-difference methods to identify the overall and dynamic effects of ZMDP. On average, the ZMDP reform was associated with the reduction in the share of revenue from drug sales (3.1%), revenue from western medicines sales (12.7%), revenue from medical care services (3.6%) and gross hospital revenue (3.4%), as well as increased government subsidies (24.4%). The ZMDP reform was not significantly associated with the number of annual outpatient and inpatient visits. In terms of dynamic effects, the share of revenue from drug sales decreased by 2.5% in the implementation year and by about 5% in the subsequent years. Revenue from western medicine sales fell substantially in the short term and continued to drop in the long term. Government subsidies went up strikingly in the short term and long term, and revenue from medical care services and gross revenue decreased only in the implementation year. The ZMDP achieved its stated goal through reducing the share of revenue from drug sales without disrupting the availability of healthcare services at TCM county hospitals. The success of ZMDP was mainly due to the huge growth in the government's financial investment in TCM hospitals.
Keywords: Zero-markup drug policy; differences-in-difference; dynamic effects; traditional Chinese medicine hospitals.
© The Author(s) 2019. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Different impacts of the zero-markup drug policy on county general and traditional Chinese medicine hospitals: evidence from Shandong province, China.Int J Equity Health. 2020 Dec 10;19(1):219. doi: 10.1186/s12939-020-01326-w. Int J Equity Health. 2020. PMID: 33302978 Free PMC article.
-
Differential effect of China's Zero Markup Drug Policy on provider-induced demand in secondary and tertiary hospitals.Front Public Health. 2024 Apr 24;12:1229722. doi: 10.3389/fpubh.2024.1229722. eCollection 2024. Front Public Health. 2024. PMID: 38721544 Free PMC article.
-
Effects on the medical revenue of comprehensive pricing reform in Chinese urban public hospitals after removing drug markups: case of Nanjing.J Med Econ. 2018 Apr;21(4):326-339. doi: 10.1080/13696998.2017.1405817. Epub 2017 Dec 1. J Med Econ. 2018. PMID: 29139303
-
Hong Kong's domestic health spending--financial years 1989/90 through 2004/05.Hong Kong Med J. 2008 Apr;14 Suppl 2:2-23. Hong Kong Med J. 2008. PMID: 18587162 Review.
-
Barriers and countermeasures in developing traditional Chinese medicine in Europe.Front Med. 2016 Sep;10(3):360-76. doi: 10.1007/s11684-016-0455-x. Epub 2016 Sep 7. Front Med. 2016. PMID: 27465827 Review.
Cited by
-
The impacts of public hospital comprehensive reform policies on hospital medicine cost, revenues and healthcare expenditures 2014-2019: An analysis of 103 tertiary public hospitals in China.Front Health Serv. 2023 Mar 7;3:1079370. doi: 10.3389/frhs.2023.1079370. eCollection 2023. Front Health Serv. 2023. PMID: 36926494 Free PMC article.
-
Medical costs and hospital utilization for hemophilia A and B urban inpatients in China: a national cross-sectional study.BMC Health Serv Res. 2022 Feb 19;22(1):230. doi: 10.1186/s12913-022-07626-x. BMC Health Serv Res. 2022. PMID: 35183186 Free PMC article.
-
Will the zero-margin drug policy reduce the economic burden of stroke patients in China?J Glob Health. 2021 Sep 30;11:08007. doi: 10.7189/jogh.11.08007. eCollection 2021. J Glob Health. 2021. PMID: 34671464 Free PMC article.
-
Impacts of the Zero-Markup Drug Policy on Hospitalization Expenses of Patients with Stroke in Western China: An Interrupted Time Series Analysis.Risk Manag Healthc Policy. 2024 Apr 3;17:777-788. doi: 10.2147/RMHP.S456977. eCollection 2024. Risk Manag Healthc Policy. 2024. PMID: 38584876 Free PMC article.
-
Systematic Review of the Effect of a Zero-Markup Policy for Essential Drugs on Healthcare Costs and Utilization in China, 2015-2021.Front Med (Lausanne). 2021 Jul 22;8:618046. doi: 10.3389/fmed.2021.618046. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34368173 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources